Literature DB >> 21845807

Use of macrogol 4000 in chronic constipation.

R De Giorgio1, R Cestari, R Corinaldesi, V Stanghellini, G Barbara, C Felicani, G Di Nardo, S Cucchiara.   

Abstract

BACKGROUND: Chronic constipation is a common functional disorder of the gastrointestinal tract, affecting up to 35% of the general population, and especially the elderly. However, its definition as perceived by the patient can vary, making it difficult to understand the problem and find appropriate therapeutic measures. The approach to chronic constipation, thus, needs a thorough understanding of the patient's complaint and the main pathophysiological mechanism requiring treatment. Lifestyle changes do not usually meet with complete patient satisfaction. Other treatments include different types of laxatives. Of these, osmotic laxatives appear one of the most effective and are, therefore, frequently prescribed.
DESIGN: This review will cover the topic of osmotic laxatives, specifically focusing on polyethylene glycol (PEG/macrogol 4000) in chronic constipation and as a key agent for bowel cleansing prior to colonoscopy. PEG formulations, including macrogol 4000, are safe, effective treatments for constipation, even in children and elderly patients. Macrogol 4000 may well be more palatable than combined formulations (macrogol 3350 with electrolytes), which could help improve adherence to the long-term treatment required for chronic constipation.
CONCLUSIONS: PEG/macrogol is also recommended as an effective option for bowel cleansing prior to colonoscopy. The improved cost-effectiveness of macrogol over other commonly prescribed laxatives, such as lactulose, should be taken into consideration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21845807

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

1.  Polyhexanide-containing solution reduces ciliary beat frequency of human nasal epithelial cells in vitro.

Authors:  Richard Birk; C Aderhold; J Stern-Sträter; K Hörmann; B A Stuck; J U Sommer
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-06       Impact factor: 2.503

2.  Effect of colic vein ligature in rats with loperamide-induced constipation.

Authors:  Flavia Neri; Giuseppe Cavallari; Matvey Tsivian; Elisa Bianchi; Rita Aldini; Monica Cevenini; Elena Guidetti; Gian Luca Piras; Milena Pariali; Bruno Nardo
Journal:  J Biomed Biotechnol       Date:  2012-05-08

3.  Chronic constipation in the elderly: a primer for the gastroenterologist.

Authors:  Roberto De Giorgio; Eugenio Ruggeri; Vincenzo Stanghellini; Leonardo H Eusebi; Franco Bazzoli; Giuseppe Chiarioni
Journal:  BMC Gastroenterol       Date:  2015-10-14       Impact factor: 3.067

Review 4.  Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel.

Authors:  Roberto De Giorgio; Furio Massimino Zucco; Giuseppe Chiarioni; Sebastiano Mercadante; Enrico Stefano Corazziari; Augusto Caraceni; Patrizio Odetti; Raffaele Giusti; Franco Marinangeli; Carmine Pinto
Journal:  Adv Ther       Date:  2021-06-04       Impact factor: 3.845

5.  Efficacy and tolerability of peg-only laxative on faecal impaction and chronic constipation in children. A controlled double blind randomized study vs a standard peg-electrolyte laxative.

Authors:  Francesco Savino; Serena Viola; Maiullari Erasmo; Giovanni Di Nardo; Salvatore Oliva; Salvatore Cucchiara
Journal:  BMC Pediatr       Date:  2012-11-15       Impact factor: 2.125

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.